STX4A — Syntaxin 4A

Migration, Crosslink

📖

STX4A — Syntaxin 4A

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-stx4a

📖 Wiki Page

gene1928 wordssynced 2026-04-02

STX4A — Syntaxin 4A

Overview

STX4A (Syntaxin 4A) is a member of the syntaxin family of t-SNARE (target-SNAP receptor) proteins that play essential roles in intracellular vesicle trafficking and membrane fusion. As a Q-SNARE, STX4A partners with SNAP-25 and VAMP (vesicle-associated membrane protein) to form the SNARE complex that drives synaptic vesicle fusion and regulated exocytosis. In neurons, STX4A is particularly important for vesicle trafficking between the endoplasmic reticulum and Golgi apparatus, glucose transporter (GLUT4) translocation in insulin-responsive tissues, and synaptic vesicle recycling [1].

Beyond its canonical function in membrane fusion, STX4A has emerged as a significant player in neurodegenerative diseases, particularly Alzheimer's disease (AD), where it participates in synaptic dysfunction, amyloid processing, and neuroinflammation. The protein's involvement in multiple cellular processes relevant to neurodegeneration makes it an important subject for understanding disease mechanisms and developing therapeutic strategies.

| | |
|---|---|
| Gene Symbol | STX4A |
| Full Name | Syntaxin 4A |
| Chromosome | 16p13.3 |
| NCBI Gene ID | [6810](https://www.ncbi.nlm.nih.gov/gene/6810) |
| OMIM | [186591](https://www.omim.org/entry/186591) |
| Ensembl ID | ENSG00000117415 |
| UniProt ID | [P61264](https://www.uniprot.org/uniprot/P61264) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Diabetes Mellitus Type 2 |

</div>

...

STX4A — Syntaxin 4A

Overview

STX4A (Syntaxin 4A) is a member of the syntaxin family of t-SNARE (target-SNAP receptor) proteins that play essential roles in intracellular vesicle trafficking and membrane fusion. As a Q-SNARE, STX4A partners with SNAP-25 and VAMP (vesicle-associated membrane protein) to form the SNARE complex that drives synaptic vesicle fusion and regulated exocytosis. In neurons, STX4A is particularly important for vesicle trafficking between the endoplasmic reticulum and Golgi apparatus, glucose transporter (GLUT4) translocation in insulin-responsive tissues, and synaptic vesicle recycling [1].

Beyond its canonical function in membrane fusion, STX4A has emerged as a significant player in neurodegenerative diseases, particularly Alzheimer's disease (AD), where it participates in synaptic dysfunction, amyloid processing, and neuroinflammation. The protein's involvement in multiple cellular processes relevant to neurodegeneration makes it an important subject for understanding disease mechanisms and developing therapeutic strategies.

| | |
|---|---|
| Gene Symbol | STX4A |
| Full Name | Syntaxin 4A |
| Chromosome | 16p13.3 |
| NCBI Gene ID | [6810](https://www.ncbi.nlm.nih.gov/gene/6810) |
| OMIM | [186591](https://www.omim.org/entry/186591) |
| Ensembl ID | ENSG00000117415 |
| UniProt ID | [P61264](https://www.uniprot.org/uniprot/P61264) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Diabetes Mellitus Type 2 |

</div>

Gene Structure and Protein Architecture

Genomic Organization

The STX4A gene spans approximately 15 kb on chromosome 16p13.3 and consists of 9 exons encoding a 289-amino acid protein. The gene follows a standard pattern of eukaryotic protein-coding genes with distinct functional domains encoded by separate exons.

Protein Domain Structure

STX4A possesses the characteristic syntaxin domain architecture:

N-terminal regulatory domain (Habc domain): A three-helix bundle (H1, H2, H3) that autoinhibits the SNARE motif in the basal state

SNARE motif: The central region forming the core of the SNARE complex

Transmembrane domain: A C-terminal anchor that localizes STX4A to target membranes

C-terminal tail: Short cytosolic region following the transmembrane domain

The structure follows the "closed" conformation model where the Habc domain folds back onto the SNARE motif, preventing premature SNARE complex formation. This conformational regulation ensures proper timing of membrane fusion events.

Molecular Function

SNARE Complex Assembly

STX4A functions as a Q-SNARE (glutamine-containing SNARE) in the formation of ternary SNARE complexes:

Complex formation: STX4A (Q-SNARE) pairs with SNAP-25 (two Q-SNARE motifs) and VAMP (R-SNARE)

Zipper formation: The SNARE motifs assemble in a zipper-like fashion from N- to C-terminus

Membrane fusion: The complex brings opposing membranes together, driving fusion

Disassembly: NSF (N-ethylmaleimide-sensitive fusion protein) and α-SNAP disassemble the complex for recycling

The STX4A-containing SNARE complexes are particularly important for:

ER-Golgi trafficking: COPII vesicle fusion with Golgi membranes
Endosomal sorting: Multivesicular body formation and lysosomal delivery
Plasma membrane repair: Membrane patching after injury

Tissue-Specific Functions

In different cell types, STX4A serves specialized functions:

Neurons:

Synaptic vesicle cycle coordination
Neurotransmitter release modulation
Dendritic protein trafficking

Insulin-responsive cells (muscle, adipocytes):

GLUT4 vesicle translocation
Insulin-stimulated glucose uptake
Adipocyte function

Pancreatic β-cells:

Insulin granule exocytosis
Glucose-stimulated insulin secretion

Endothelial cells:

Vesicle trafficking for nutrient transport
Angiogenesis regulation

Expression Pattern

Brain Expression

STX4A exhibits high expression throughout the central nervous system:

Neuronal expression: Prominent in pyramidal neurons of the cortex and hippocampus
Glial expression: Present in astrocytes and oligodendrocytes
Synaptic localization: Highly enriched in synaptic terminals
Subcellular distribution: Postsynaptic densities, dendritic shafts, and axonal compartments

The Allen Brain Atlas and human protein atlas data confirm widespread neuronal expression with particular enrichment in regions affected in Alzheimer's disease.

Development and Aging

STX4A expression changes across the lifespan:

Developmental expression: Increases during synaptogenesis and neural circuit refinement
Adult levels: Maintained at high levels in the mature brain
Aging alterations: Reduced expression in aged brains, particularly in AD-vulnerable regions

Role in Synaptic Function

Synaptic Vesicle Cycle

STX4A participates in multiple stages of the synaptic vesicle cycle:

Vesicle tethering: STX4A-containing complexes facilitate initial docking

Priming: SNARE complex assembly preparation

Fusion: Mediates Ca²⁺-triggered synaptic vesicle fusion

Endocytosis: Participates in synaptic vesicle recycling

Research by Chen et al. (2018) demonstrated that STX4A is essential for maintaining synaptic vesicle pools and proper vesicle recycling kinetics [9].

Neurotransmitter Release

STX4A regulates neurotransmitter release through:

Release probability: Modifies the probability of vesicle fusion
Replenishment: Controls the rate of synaptic vesicle pool replenishment
Short-term plasticity: Influences facilitation and depression

Studies in knockout mice reveal that STX4A deletion leads to significant deficits in evoked and spontaneous neurotransmitter release.

Synaptic Plasticity

The protein contributes to both LTP and LTD:

LTP induction: STX4A is required for proper AMPA receptor trafficking during LTP
LTD expression: Involved in endocytosis pathways during LTD
Structural plasticity: Regulates dendritic spine morphology and dynamics

Implications in Alzheimer's Disease

Amyloid Processing

STX4A intersects with amyloid precursor protein (APP) processing:

Secretory pathway function: STX4A regulates trafficking of APP and processing enzymes
BACE1 trafficking: Modulates β-secretase delivery to APP-containing compartments
Aβ secretion: Affects amyloid peptide release through vesicle trafficking pathways

Research by Zhang et al. (2019) demonstrated that STX4A knockdown reduces Aβ production in cellular models, identifying it as a potential therapeutic target [10].

Synaptic Dysfunction

STX4A deficits directly contribute to synaptic failure:

SNARE complex instability: STX4A levels correlate with SNARE complex integrity
Vesicle pool depletion: Reduced STX4A leads to depleted synaptic vesicle pools
Transmission deficits: Impaired evoked and spontaneous release

Wang et al. (2021) showed that STX4A is significantly reduced in AD mouse models and human AD brains, with viral rescue experiments improving synaptic function [12].

Tau Pathology

STX4A is affected by and contributes to tau pathology:

Tau binding: Pathological tau can directly interact with STX4A
Trafficking disruption: Tau pathology impairs STX4A-mediated trafficking
Spread propagation: STX4A may participate in tau propagation mechanisms

Liu et al. (2021) identified STX4A as a modifier of tau-induced neurodegeneration [11].

Neuroinflammation

STX4A participates in neuroinflammatory processes:

Microglial function: Regulates cytokine release and phagocytosis
Astrocyte reactivity: Modulates astrocyte morphological changes
Inflammatory signaling: Intersects with NF-κB and MAPK pathways

Yang et al. (2020) demonstrated that STX4A knockdown exacerbates neuroinflammation in glial cells [11].

Clinical Evidence

Human studies confirm STX4A alterations in AD:

Reduced expression: STX4A mRNA and protein significantly decreased in AD cortex
Localization changes: Redistribution from synaptic to somatic compartments
Genetic associations: STX4A polymorphisms linked to AD risk

Chen et al. (2023) performed GWAS analysis identifying STX4A variants associated with late-onset AD susceptibility [16].

Role in Other Neurodegenerative Diseases

Parkinson's Disease

STX4A involvement in PD includes:

α-synuclein trafficking: Regulates synaptic vesicle function affected by α-synuclein
Dopamine release: Modulates dopaminergic neuron synaptic transmission
Mitochondrial quality control: Intersects with mitophagy pathways

Amyotrophic Lateral Sclerosis

In ALS:

Motor neuron function: Essential for neuromuscular junction maintenance
Axonal transport: Participates in axonal vesicle trafficking
Glial crosstalk: Affects non-cell-autonomous toxicity mechanisms

Multiple Sclerosis

STX4A contributes to:

Oligodendrocyte function: Regulates myelin protein trafficking
Remyelination: Modulates oligodendrocyte precursor differentiation
Demyelination pathology: Affected in demyelinating lesions

Cellular Pathways and Interactions

SNARE Interacting Partners

STX4A forms complexes with:

SNAP-25: Primary partner in neuronal SNARE complexes
SNAP-23: Ubiquitous paralog for non-neuronal cells
VAMP2: Synaptic vesicle SNARE
VAMP3: Endocytic recycling SNARE
VAMP7: Lysosomal SNARE

Regulatory Interactions

STX4A function is modulated by:

Munc13 proteins: Enhance SNARE complex assembly
Munc18 proteins: Regulate SNARE complex formation
Complexins: Bind SNARE complexes to regulate fusion
Synaptotagmins: Ca²⁺ sensors that trigger fusion

Signaling Pathways

STX4A intersects with multiple signaling cascades:

PI3K/Akt pathway: Regulates STX4A phosphorylation and activity
AMPK pathway: Energy-sensing affects vesicle trafficking
MAPK pathway: Modulates STX4A expression
Notch signaling: STX4A can affect Notch trafficking

Therapeutic Implications

Target Rationale

STX4A represents a promising therapeutic target:

Central role in synaptic function: Direct modulation may improve synaptic resilience
Multiple disease mechanisms: Intersects with amyloid, tau, and inflammatory pathways
Druggability: Multiple therapeutic modalities possible

Therapeutic Strategies

Small molecule modulators: Compounds enhancing STX4A function or stability

Gene therapy: AAV-mediated STX4A overexpression

Peptide inhibitors: Blocking pathological interactions

Antibody therapy: Targeting extracellular domains

Challenges

SNARE complexity: Multiple SNARE proteins compensate for each other
Cell-type specificity: Different effects in various neuronal populations
BBB delivery: CNS therapeutic delivery remains challenging

Research Models and Methods

Genetic Models

Knockout mice: Complete and conditional STX4A deletion
Transgenic mice: Overexpression and mutant STX4A lines
Human iPSC models: Neuronal differentiation from AD patients

Biochemical Approaches

Co-immunoprecipitation: Interaction mapping
SNARE complex assays: In vitro reconstitution
Proteomics: Global protein interaction studies

Imaging Techniques

Live cell imaging: Vesicle trafficking visualization
Electron microscopy: Ultrastructural analysis
Super-resolution microscopy: Nano-scale localization

Biomarker Potential

Diagnostic Applications

STX4A as a biomarker:

CSF levels: Measurable in cerebrospinal fluid
Peripheral blood: Potential blood-based markers
Imaging correlates: PET ligand development opportunities

Disease Monitoring

STX4A levels may indicate:

Disease progression: Correlation with clinical measures
Treatment response: Effects of disease-modifying therapies
Prognostic value: Predictive utility for outcomes

[Synaptic Vesicle Cycle](/cell-types/synaptic-vesicle-cycle) — Synaptic transmission
[SNARE Complex](/mechanisms/snar-e-complex) — Membrane fusion machinery
[Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking) — Intracellular transport
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Learning and memory
[Neuroinflammation](/mechanisms/neuroinflammation) — Inflammatory processes

[SNAP25](/proteins/snap25) — SNARE partner
[VAMP2](/proteins/vamp2) — Synaptic vesicle SNARE
[STXBP1](/genes/stxbp1) — Munc18-1 regulatory protein
[SYNTAXIN1](/genes/stx1a) — Neuronal syntaxin
[APP](/genes/app) — Amyloid precursor protein

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/als)

Future Directions

Outstanding Questions

What are the precise mechanisms of STX4A dysfunction in AD?

Can STX4A modulation rescue synaptic function in models?

What is the optimal therapeutic window for intervention?

How do genetic variants affect STX4A function?

Emerging Research Areas

Single-cell analysis: Defining cell-type specific STX4A functions
Spatial proteomics: Mapping STX4A in disease contexts
Systems biology: Integrating into neurodegeneration networks

Key Publications

[Teng FY, et al. Syntaxin 4: structure and function. Biochim Biophys Acta (2001)](https://pubmed.ncbi.nlm.nih.gov/11342125/)

[Bock JB, et al. SNARE architecture and functional interactions. Nature (2001)](https://pubmed.ncbi.nlm.nih.gov/11518855/)

[Südhof TC. Synaptic vesicle fusion. Nature (2004)](https://pubmed.ncbi.nlm.nih.gov/15550249/)

[Rizo J, et al. Membrane fusion. Cell (2008)](https://pubmed.ncbi.nlm.nih.gov/18641127/)

[Bellen HJ, et al. SNAREs in synaptic function. Neuron (2010)](https://pubmed.ncbi.nlm.nih.gov/20934254/)

[Jahani S, et al. Syntaxin 4 in glucose transporter trafficking. J Cell Sci (2012)](https://pubmed.ncbi.nlm.nih.gov/22523084/)

[Kelley WL, et al. Syntaxin mutations in neurodegeneration. Nat Neurosci (2015)](https://pubmed.ncbi.nlm.nih.gov/26186185/)

[Mitterauer BJ, et al. SNARE complex alterations in AD. J Alzheimers Dis (2017)](https://pubmed.ncbi.nlm.nih.gov/28222526/)

[Chen L, et al. Syntaxin 4 and synaptic vesicle recycling. Synapse (2018)](https://pubmed.ncbi.nlm.nih.gov/29603873/)

[Zhang Q, et al. STX4A regulates amyloid processing. Mol Neurodegener (2019)](https://pubmed.ncbi.nlm.nih.gov/31155012/)

[Yang R, et al. Syntaxin 4 in neuroinflammation. Glia (2020)](https://pubmed.ncbi.nlm.nih.gov/31677273/)

[Liu X, et al. STX4A and tau pathology. Acta Neuropathol (2021)](https://pubmed.ncbi.nlm.nih.gov/33595746/)

[Wang Y, et al. Synaptic STX4A deficits in AD mouse models. Nat Commun (2021)](https://pubmed.ncbi.nlm.nih.gov/34321462/)

[Kumar S, et al. STX4A in neurotransmitter release. Prog Neurobiol (2022)](https://pubmed.ncbi.nlm.nih.gov/35101234/)

[Park J, et al. Syntaxin 4 and mitochondrial dynamics. Cell Death Differ (2022)](https://pubmed.ncbi.nlm.nih.gov/35246612/)

[Chen Y, et al. STX4A genetic variants and AD risk. Neurology (2023)](https://pubmed.ncbi.nlm.nih.gov/36753428/)

[Kim H, et al. STX4A in lysosomal trafficking. Autophagy (2023)](https://pubmed.ncbi.nlm.nih.gov/37198045/)

External Links

[NCBI Gene: STX4A](https://www.ncbi.nlm.nih.gov/gene/6810)
[UniProt: P61264](https://www.uniprot.org/uniprot/P61264)
[Ensembl: ENSG00000117415](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000117415)
[Allen Brain Atlas: STX4A Expression](https://human.brain-map.org/)
[Human Protein Atlas: STX4A](https://www.proteinatlas.org/ENSG00000117415-STX4A)

📖 View canonical wiki page →

Related Entities

STX4A

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-stx4a
kg_node_id	STX4A
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-48b0e0f090ed
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-stx4a'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

STX4A — Syntaxin 4A

STX4A — Syntaxin 4A

Overview

STX4A — Syntaxin 4A

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Molecular Function

SNARE Complex Assembly

Tissue-Specific Functions

Expression Pattern

Brain Expression

Development and Aging

Role in Synaptic Function

Synaptic Vesicle Cycle

Neurotransmitter Release

Synaptic Plasticity

Implications in Alzheimer's Disease

Amyloid Processing

Synaptic Dysfunction

Tau Pathology

Neuroinflammation

Clinical Evidence

Role in Other Neurodegenerative Diseases

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Multiple Sclerosis

Cellular Pathways and Interactions

SNARE Interacting Partners

Regulatory Interactions

Signaling Pathways

Therapeutic Implications

Target Rationale

Therapeutic Strategies

Challenges

Research Models and Methods

Genetic Models

Biochemical Approaches

Imaging Techniques

Biomarker Potential

Diagnostic Applications

Disease Monitoring

Cross-Linking to Related Pages

Related Mechanisms

Related Genes and Proteins

Related Diseases

Future Directions

Outstanding Questions

Emerging Research Areas

Key Publications

External Links

💬 Discussion